Last week started with another encouraging announcement for a covid-19 vaccine after Moderna said that its candidate was 94.5% effective in Phase 3 trials. The update came just a week after Pfizer’s vaccine candidate, developed in partnership with BioNTech, delivered
Wall Street started the week on a strong note as investors cheered news of encouraging data from late-stage trials of the covid-19 vaccine candidate being developed by Pfizer and BioNTech. The companies disclosed that their vaccine candidate is more than 90% effective
US stocks started the election week with a bang, as investors looked forward to the end of uncertainty. As the week progressed, Democratic party nominee Joe Biden consolidated his lead, and the Republicans took control of the Senate. The markets
Wall Street started the week with massive losses as coronavirus cases spiked in the US and Europe. Investor sentiment remained tepid as various European countries reinforced lockdown measures, fueling concerns over a slowdown in the rebound of the global economy.
Investors shifted their focus to the beginning of the earnings season last week. US stocks started the week with a bang despite the stalled talks over fresh fiscal stimulus and rising covid-19 infections. Markets also turned their attention to the
News of improvement in US President Donald Trump’s health after testing positive for covid-19 helped Wall Street record sharp gains at the start of the week. Investors welcomed the news of Trump’s discharge Monday night from Walter Reed Medical Center.